Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Medtronic
Chinese Patent Office
Merck
Citi
Fish and Richardson
Cipla
Chubb
AstraZeneca

Generated: August 16, 2017

DrugPatentWatch Database Preview

Atomoxetine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for atomoxetine hydrochloride and what is the scope of atomoxetine hydrochloride freedom to operate?

Atomoxetine hydrochloride
is the generic ingredient in two branded drugs marketed by Lilly, Aurobindo Pharma Ltd, Zydus Pharms Usa Inc, Glenmark Pharms Ltd, Teva Pharms Usa, and Apotex Inc, and is included in six NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for atomoxetine hydrochloride. Thirteen suppliers are listed for this compound. There are seven tentative approvals for this compound.

Summary for Generic Name: atomoxetine hydrochloride

Tradenames:2
Patents:1
Applicants:6
NDAs:6
Drug Master File Entries: see list14
Suppliers / Packagers: see list13
Bulk Api Vendors: see list42
Clinical Trials: see list2,357
Patent Applications: see list1,907
Therapeutic Class:Central Nervous System Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:atomoxetine hydrochloride at DailyMed

Pharmacology for Ingredient: atomoxetine hydrochloride

Tentative approvals for ATOMOXETINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe10MGCAPSULE; ORAL
► Subscribe► Subscribe100MGCAPSULE; ORAL
► Subscribe► Subscribe80MGCAPSULE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL078983-001May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079022-004May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms Ltd
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079019-003May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079017-003Sep 17, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079022-003May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: atomoxetine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly
STRATTERA
atomoxetine hydrochloride
CAPSULE;ORAL021411-006Nov 26, 2002► Subscribe► Subscribe
Lilly
STRATTERA
atomoxetine hydrochloride
CAPSULE;ORAL021411-001Nov 26, 2002► Subscribe► Subscribe
Lilly
STRATTERA
atomoxetine hydrochloride
CAPSULE;ORAL021411-007Feb 14, 2005► Subscribe► Subscribe
Lilly
STRATTERA
atomoxetine hydrochloride
CAPSULE;ORAL021411-003Nov 26, 2002► Subscribe► Subscribe
Lilly
STRATTERA
atomoxetine hydrochloride
CAPSULE;ORAL021411-008Feb 14, 2005► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Julphar
Chinese Patent Office
Fish and Richardson
McKinsey
Queensland Health
Daiichi Sankyo
Baxter
UBS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot